The advent of CAR-T (Chimeric Antigen Receptor T-cell) therapies and other advanced cell and gene therapies (CGTs) marks a revolutionary shift in treating complex diseases like cancer and genetic disorders. These therapies rely on living cells that are genetically modified to fight disease, making them highly personalized and sensitive products. Shipping such advanced therapies is far more complex than traditional pharmaceuticals, requiring specialized logistics to maintain product integrity and ensure patient safety.
In this blog, we explore the key considerations when shipping CAR-T and other advanced therapies, highlighting the challenges and best practices to support successful delivery.
-
Maintainingthe Cold Chain: Temperature Control Is Critical
CAR-T cells and many other advanced therapies are often cryopreserved at ultra-low temperatures, typically below -150°C, using liquid nitrogen vapor shippers. Any deviation from required temperature ranges can compromise cell viability and potency, potentially rendering the therapy ineffective or unsafe.
Logistics providers must ensure continuous temperature monitoring during transport, use validated packaging solutions, and have robust contingency plans to address any temperature excursions immediately.
-
Ensuring Timely Delivery: The Patient’s Treatment Schedule Depends on It
Timing is crucial. CAR-T therapies are often autologous, meaning the patient’s own cells are collected, modified, and then reinfused. Delays in shipping either the patient’s collected cells to manufacturing or the final therapy back to the clinic can impact treatment schedules and patient outcomes.
Reliable logistics partners coordinate complex shipments with precise timing, managing customs clearance, transport modes, and last-mile delivery to guarantee on-time arrival.
-
Preserving Chain of Identity and Chain of Custody
Since CAR-T therapies are personalized, maintaining an unbroken chain of identity (linking the product uniquely to the patient) and chain of custody (tracking control and handling from collection to delivery) is mandatory. Any mix-up or loss of traceability can have severe clinical consequences.
Shipping providers use barcoding, RFID tracking, and secure documentation systems to maintain full traceability throughout the supply chain, ensuring patient safety and regulatory compliance.
-
Compliance with Regulatory Requirements
Advanced therapies fall under strict regulatory frameworks such as FDA guidelines, EMA regulations, and local customs requirements. Shipping these products requires adherence to these regulations, including validated temperature controls, proper labeling, and documentation.
Working with experienced life science logistics companies helps manufacturers and healthcare providers navigate these complex regulations efficiently.
-
Specialized Packaging and Handling
Packaging for CAR-T and other advanced therapies must be specially designed to withstand extreme temperatures and physical shocks during transit. Cryoshippers with liquid nitrogen vapor, insulated containers, and shock-absorbent materials protect the product.
Moreover, trained personnel are essential for handling, loading, and unloading these sensitive shipments to avoid damage or contamination.
-
Risk Management and Contingency Planning
Unexpected delays, equipment failures, or extreme weather conditions can jeopardize shipments. Robust risk management practices, including real-time shipment tracking, backup transportation options, and emergency protocols, are critical to mitigate risks and protect the product.
-
Communication and Collaboration Across Stakeholders
Successful shipping of CAR-T therapies requires seamless coordination between manufacturers, logistics providers, healthcare facilities, and couriers. Transparent communication channels ensure everyone is aligned on schedules, product status, and any issues that arise.
Conclusion
Shipping CAR-T and other advanced therapies requires specialized knowledge, meticulous handling, and strict adherence to regulatory standards to protect these delicate, life-saving treatments. From maintaining ultra-low temperatures to ensuring timely and compliant delivery, every detail in the supply chain is critical.
By focusing on these key considerations and partnering with experienced life science logistics providers, manufacturers and healthcare teams can confidently deliver advanced therapies that improve patient outcomes and push personalized medicine forward.
At Biocair, we are dedicated to supporting the complex needs of CAR-T and cell & gene therapies. With our expertise in precision logistics, cold chain management, and regulatory compliance, we ensure your therapies arrive safely, on time, and in optimal condition—helping bridge science and patient care every step of the way.
Related Contents:
Biocair is a global logistics provider specializing in pharmaceutical, biotechnology and life sciences supply chain solutions with nearly 40 years of experience. By assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance, Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled solutions.
